| QT prolongation, torsades de pointes, and psychotropic medications: a 5-year update SR Beach, CM Celano, AM Sugrue, C Adams, MJ Ackerman, ... Psychosomatics 59 (2), 105-122, 2018 | 194 | 2018 |
| Contemporary outcomes in patients with long QT syndrome RK Rohatgi, A Sugrue, JM Bos, BC Cannon, SJ Asirvatham, C Moir, ... Journal of the American College of Cardiology 70 (4), 453-462, 2017 | 125 | 2017 |
| Pulsed electric fields for cardiac ablation and beyond: a state-of-the-art review E Maor, A Sugrue, C Witt, VR Vaidya, CV DeSimone, SJ Asirvatham, ... Heart rhythm 16 (7), 1112-1120, 2019 | 97 | 2019 |
| Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience A Sugrue, V Vaidya, C Witt, CV DeSimone, O Yasin, E Maor, AM Killu, ... Journal of Interventional Cardiac Electrophysiology 55, 251-265, 2019 | 63 | 2019 |
| Association of serum magnesium on mortality in patients admitted to the intensive cardiac care unit N Naksuk, T Hu, C Krittanawong, C Thongprayoon, S Sharma, JY Park, ... The American journal of medicine 130 (2), 229. e5-229. e13, 2017 | 57 | 2017 |
| Three-dimensional printed biopatches with conductive ink facilitate cardiac conduction when applied to disrupted myocardium DM Pedrotty, V Kuzmenko, E Karabulut, AM Sugrue, C Livia, VR Vaidya, ... Circulation: Arrhythmia and Electrophysiology 12 (3), e006920, 2019 | 55 | 2019 |
| Irreversible electroporation for the treatment of cardiac arrhythmias A Sugrue, E Maor, A Ivorra, V Vaidya, C Witt, S Kapa, S Asirvatham Expert review of cardiovascular therapy 16 (5), 349-360, 2018 | 46 | 2018 |
| Elimination of purkinje fibers by electroporation reduces ventricular fibrillation vulnerability C Livia, A Sugrue, T Witt, MD Polkinghorne, E Maor, S Kapa, HI Lehmann, ... Journal of the American Heart Association 7 (15), e009070, 2018 | 43 | 2018 |
| Intrapulmonary vein ablation without stenosis: a novel balloon‐based direct current electroporation approach CM Witt, A Sugrue, D Padmanabhan, V Vaidya, S Gruba, J Rohl, ... Journal of the American Heart Association 7 (14), e009575, 2018 | 43 | 2018 |
| Right ventricular dysfunction and long-term risk of sudden cardiac death in patients with and without severe left ventricular dysfunction N Naksuk, N Tan, D Padmanabhan, K Kancharla, N Makkar, ... Circulation: Arrhythmia and Electrophysiology 11 (6), e006091, 2018 | 38 | 2018 |
| Noninvasive assessment of dofetilide plasma concentration using a deep learning (neural network) analysis of the surface electrocardiogram: a proof of concept study ZI Attia, A Sugrue, SJ Asirvatham, MJ Ackerman, S Kapa, PA Friedman, ... PLoS One 13 (8), e0201059, 2018 | 37 | 2018 |
| Combined local impedance and contact force for radiofrequency ablation assessment K Garrott, J Laughner, S Gutbrod, A Sugrue, A Shuros, M Sulkin, O Yasin, ... Heart rhythm 17 (8), 1371-1380, 2020 | 35 | 2020 |
| Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation A Sugrue, D Sanborn, M Amin, M Farwati, H Sridhar, A Ahmed, R Mehta, ... The American journal of cardiology 144, 52-59, 2021 | 34 | 2021 |
| Electroporation of epicardial autonomic ganglia: safety and efficacy in medium‐term canine models D Padmanabhan, N Naksuk, AK Killu, S Kapa, C Witt, A Sugrue, ... Journal of cardiovascular electrophysiology 30 (4), 607-615, 2019 | 31 | 2019 |
| Echocardiography-guided risk stratification for long QT syndrome A Sugrue, M van Zyl, N Enger, K Mancl, BW Eidem, JK Oh, JM Bos, ... Journal of the American College of Cardiology 76 (24), 2834-2843, 2020 | 29 | 2020 |
| Electrocardiographic predictors of torsadogenic risk during dofetilide or sotalol initiation: utility of a novel T wave analysis program A Sugrue, V Kremen, B Qiang, SH Sheldon, CV DeSimone, Y Sapir, ... Cardiovascular drugs and therapy 29, 433-441, 2015 | 28 | 2015 |
| Cardiac ablation with pulsed electric fields: principles and biophysics A Sugrue, E Maor, F Del-Carpio Munoz, AM Killu, SJ Asirvatham Europace 24 (8), 1213-1222, 2022 | 27 | 2022 |
| Identification of concealed and manifest long QT syndrome using a novel T wave analysis program A Sugrue, PA Noseworthy, V Kremen, JM Bos, B Qiang, RK Rohatgi, ... Circulation: Arrhythmia and Electrophysiology 9 (7), e003830, 2016 | 24 | 2016 |
| Feasibility of selective cardiac ventricular electroporation A Sugrue, VR Vaidya, C Livia, D Padmanabhan, A Abudan, A Isath, T Witt, ... PLoS One 15 (2), e0229214, 2020 | 23 | 2020 |
| Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy A Sugrue, AM Killu, CV DeSimone, AA Chahal, JC Vogt, V Kremen, JJ Hai, ... Open Heart 4 (1), e000561, 2017 | 22 | 2017 |
Peter Noseworthy, MDChair, Electrophysiology, Professor of Medicine, Mayo ClinicE-mailová adresa ověřena na: mayo.edu
